It has been an incredible week of positive news for ImmunityBio.

Intelligent Bio Solutions stock was down 14.06% in pre-market trading on Friday, following a 132.44% rally on the previous ...

ImmunityBio, Inc. is upgraded to Buy reflecting improving Anktiva data & potential label expansions in NMIBC and NSCLC. Read ...

Shares surged 30% Thursday after reporting 700% Anktiva revenue growth and securing Saudi FDA approvals for lung and bladder ...

After diving over 17% on January 2, shares in biopharma company Intelligent Bio Solutions ($INBS) are back with a rally, ...

Intelligent Bio Solutions stock rises after announcing a manufacturing partnership targeting over 40% cost savings, major margin improvement, and expanded global production capacity ahead of planned U ...

Passage Bio, Inc. announced a reverse stock split of its common stock at a ratio of 1-for-20, effective July 14, 2025, in order to meet Nasdaq's minimum bid price requirement of $1.00 per share. The ...

Nuvation Bio enrolled the first patient in a late-stage study of Ibtrozi. The bigger story, though, was a Wall Street analyst's initiation of coverage on the stock. Shares of Nuvation Bio (NYSE: NUVB) ...

Bio-Rad Laboratories BIO recently announced the launch of four new Droplet Digital PCR (ddPCR) platforms. The newly introduced instruments include the company's QX Continuum ddPCR system, along with ...

Investing.com -- Instil Bio (NASDAQ:TIL) stock fell 15% Tuesday after the company announced that its wholly-owned subsidiary Axion Bio has decided to discontinue clinical development of AXN-2510 and ...